BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 8:55:40 AM | Browse: 663 | Download: 2200
 |
Received |
|
2020-12-24 22:14 |
|
Peer-Review Started |
|
2020-12-24 22:15 |
|
First Decision by Editorial Office Director |
|
2021-02-14 00:58 |
|
Return for Revision |
|
2021-02-17 11:30 |
|
Revised |
|
2021-02-26 12:40 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-04-22 07:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-04-22 12:10 |
|
Articles in Press |
|
2021-04-22 12:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-20 14:25 |
|
Publish the Manuscript Online |
|
2021-05-26 08:55 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Retrospective Study |
| Article Title |
Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Serdar Kabatas, Erdinç Civelek, Eyüp Can Savrunlu, Necati Kaplan, Osman Boyalı, Furkan Diren, Halil Can, Ali Genç, Tunç Akkoc and Erdal Karaöz |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Serdar Kabatas, MD, Full Professor, Department of Neurosurgery, University of Health Sciences, Gaziosmanpaşa Training and Research Hospital, Karayolları Mahallesi, Osmanbey Caddesi 616. Sokak No. 10, Gaziosmanpaşa, Istanbul 34255, Türkiye. kabatasserdar@hotmail.com |
| Key Words |
Hypoxic-ischemic encephalopathy; Pediatric; Stem cell; Wharton jelly |
| Core Tip |
Hypoxic-ischemic encephalopathy (HIE) emerges as one of the leading causes of morbidity and mortality in children. There are a limited number of options for treating HIE. Recently, stem cell and cellular therapies appear to be a potential treatment option for ischemic brain injury caused by HIE. The aim of this phase I open-label clinical study is to investigate the efficacy and safety of one of these stem cell-based therapies in a group of pediatric patients with HIE. Both the triple-route and multiple Wharton`s jelly-derived mesenchymal stem cells administrations were safe and effective in pediatric patients with HIE with significant neurological and functional improvements. |
| Publish Date |
2021-05-26 08:55 |
| Citation |
Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Boyalı O, Diren F, Can H, Genç A, Akkoç T, Karaöz E. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study. World J Stem Cells 2021; 13(5): 470-484 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i5/470.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i5.470 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
